Variant report
| Variant | esv3352303 |
|---|---|
| Chromosome Location | chrX:6188602-6190500 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
Variant overlapped rSNPs/rCNVs (count:42 , 50 per page) page:
1
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs113606528 | chrX:6188631-6188632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs144339330 | chrX:6188645-6188646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs370158798 | chrX:6188649-6188650 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs146721377 | chrX:6188782-6188783 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs148463392 | chrX:6188792-6188793 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs142629027 | chrX:6188834-6188835 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs540446647 | chrX:6188874-6188875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs185726774 | chrX:6188967-6188968 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs560352218 | chrX:6188979-6188980 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs7064335 | chrX:6188992-6188993 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs549089735 | chrX:6189028-6189029 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs140889382 | chrX:6189059-6189060 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs375781455 | chrX:6189124-6189125 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs190093285 | chrX:6189348-6189349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs59976283 | chrX:6189390-6189391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs397701265 | chrX:6189391-6189392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs181563234 | chrX:6189449-6189450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs185358265 | chrX:6189563-6189564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs112371623 | chrX:6189608-6189609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs4826720 | chrX:6189681-6189682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs73461323 | chrX:6189694-6189695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs375924982 | chrX:6189749-6189750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs556743114 | chrX:6189776-6189777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs201576527 | chrX:6189824-6189825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs113328778 | chrX:6189848-6189849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs201501972 | chrX:6189851-6189852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs190171174 | chrX:6189886-6189887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs199711664 | chrX:6189910-6189911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs111737783 | chrX:6190048-6190049 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs141211396 | chrX:6190049-6190050 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 31 | rs146964166 | chrX:6190111-6190112 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs181303351 | chrX:6190113-6190114 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs114383048 | chrX:6190153-6190154 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs190955500 | chrX:6190292-6190293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs4079058 | chrX:6190306-6190307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs575438779 | chrX:6190331-6190332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs375993950 | chrX:6190349-6190350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs184008480 | chrX:6190355-6190356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs188812981 | chrX:6190363-6190364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs57480592 | chrX:6190385-6190386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs1809193 | chrX:6190421-6190422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs60992289 | chrX:6190424-6190425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| turner syndrome | 20877625 | CNVD |
| Kallmann Syndrome 1 | 22470819 | CNVD |
| short stature | 22470819 | CNVD |
| Oro-facial digital syndrome | 19023858 | CNVD |
| Oro-facial digital syndrome | 21572526 | CNVD |
| Aicardi syndrome | 21572526 | CNVD |
| Vermis hypoplasia | 21569638 | CNVD |
| Opitz syndrome | 21569638 | CNVD |
| Opitz syndrome | 21572526 | CNVD |
| Oro-facial digital syndrome | 21569638 | CNVD |
| Abnormal corpus callosum | 21572526 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Seminomas | 18059402 | CNVD |
| abnormal development | 18461090 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Cancer | 21637783 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Cancer | 16751803 | CNVD |
| Intellectual disability | 23615299 | CNVD |
| Neuroblastoma | 18923191 | CNVD |
| Burkitt''s lymphoma | 20823134 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Acute lymphoblastic leukemia | 17690704 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Schizophrenia | 23904455 | CNVD |
| Olfactory neuroblastoma | 18408657 | CNVD |
| infertile | 22614455 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Mental retardation | 17406619 | CNVD |
| Intellectual disability | 22102821 | CNVD |
| Autism | 22495311 | CNVD |
| Glioblastoma multiforme | 22286061 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Cancer | 20581869 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Multiple myeloma | 20724749 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
| Breast cancer | 21785460 | CNVD |
| XY gonadal dysgenesis | 20685758 | CNVD |
| Breast cancer | 21364760 | CNVD |
| Mental retardation | 20486941 | CNVD |
| Abnormal phenotypes | 21355048 | CNVD |
| Congenital abnormalities | 21549014 | CNVD |
| Developmental delay | 21549014 | CNVD |
| Mental retardation | 21549014 | CNVD |
| Microphthalmia | 21572526 | CNVD |
| Steroid sulfatase deficiency | 21549014 | CNVD |
| Attention deficit hyperactivity disorder | 21355048 | CNVD |
| Ichthyosis | 21355048 | CNVD |
| Mental retardation | 21355048 | CNVD |
| Immune disease | 21076436 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chrX:6188400-6188800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
| 2 | chrX:6188400-6189000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
| 3 | chrX:6188400-6190000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
| 4 | chrX:6188600-6188800 | Enhancers | H9 Cell Line | embryonic stem cell |
| 5 | chrX:6188600-6189200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
| 6 | chrX:6188800-6189000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
| 7 | chrX:6188800-6194200 | Weak transcription | H9 Cell Line | embryonic stem cell |
| 8 | chrX:6189000-6190000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
| 9 | chrX:6189200-6190000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
| 10 | chrX:6190000-6190200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
| 11 | chrX:6190000-6190400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
| 12 | chrX:6190000-6190400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
| 13 | chrX:6190200-6196200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
| 14 | chrX:6190400-6194000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |





